Inotiv (LTS:0HN9) Other Long-Term Liabilities : $17.9 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Inotiv Other Long-Term Liabilities?

Inotiv's other long-term liabilities for the quarter that ended in Jun. 2024 was $17.9 Mil.

Inotiv's quarterly other long-term liabilities increased from Dec. 2023 ($1.0 Mil) to Mar. 2024 ($21.1 Mil) but then declined from Mar. 2024 ($21.1 Mil) to Jun. 2024 ($17.9 Mil).

Inotiv's annual other long-term liabilities increased from Sep. 2021 ($0.5 Mil) to Sep. 2022 ($6.5 Mil) but then declined from Sep. 2022 ($6.5 Mil) to Sep. 2023 ($6.4 Mil).

Inotiv Other Long-Term Liabilities Historical Data

The historical data trend for Inotiv's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inotiv Other Long-Term Liabilities Chart

Inotiv Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Inotiv Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Inotiv Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Inotiv Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Inotiv's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Inotiv Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inotiv Inc (LTS:0HN9) » Definitions » Other Long-Term Liabilities

Comparable Companies

OCX PRPH STIM XGN APDN VNRX BIAF ENZ SLDX TTOO TMO DHR XSWX:LONN IQV A IDXX MTD ICLR ILMN WAT

Traded in Other Exchanges

NOTV:USA BS50:Germany BS50:Germany

Address

2701 Kent Avenue, West Lafayette, IN, USA, 47906

Website

https://www.inotivco.com

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Inotiv Headlines

No Headlines